donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

KNSA Kiniksa Pharmaceuticals

10.300
-0.380-3.56%
Close 06/24 16:00 ET
10.30000.00%
Post Mkt Price 06/24 16:16 ET
High
10.960
Open
10.570
Turnover
6.12M
Low
10.165
Pre Close
10.680
Volume
590.31K
Market Cap
713.54M
P/E(TTM)
Loss
52wk High
16.679
Shares
69.28M
P/E(Static)
Loss
52wk Low
7.360
Float Cap
275.39M
Bid/Ask %
-66.67%
Historical High
32.880
Shs Float
26.74M
Volume Ratio
1.24
Historical Low
5.010
Dividend TTM
--
Div Yield TTM
35
P/B
4.29
Dividend LFY
--
Div Yield LFY
339.81%
Turnover Ratio
2.21%
Amplitude
7.44%
Avg Price
10.374
Lot Size
1
Float Cap
275.39M
Bid/Ask %
-66.67%
Historical High
32.880
Shs Float
26.74M
Volume Ratio
1.24
Historical Low
5.010
Dividend TTM
--
P/B
4.29
Dividend LFY
--
Turnover Ratio
2.21%
Amplitude
7.44%
Avg Price
10.374
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody inhibitor that completed Phase II clinical trials for the treatment of giant cell arteritis; Vixarelimab, a monoclonal antibody, which is in Phase 2a clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-404, a monoclonal antibody inhibitor of the CD40- CD154 interaction, a T-cell co-stimulatory signal critical for B-cell maturation, immunoglobulin class switching, and type 1 immune response. Kiniksa Pharmaceuticals, Ltd. was incorporated in 2015 and is based in Hamilton, Bermuda.
CEO: Patel, Sanj K.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...